Home › Therapeutic areas › Ophthalmology › Stargardt Disease
Stargardt Disease (2 companies)
Companies with an active program in Stargardt Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| BLTE | Belite Bio | MetabolicOphthalmology Rare | 1 | NDA Submitted | $6.21B | 6 |
| OCGN | Ocugen | Infectious DiseaseOphthalmology Rare | 1 | Phase 3 | $314M | 12 |
No companies match.